| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4e0c5ea65fcf918dc91f411f094b960 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-50 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate |
2008-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f908d06ab5274f6fdfd1daa6e13e7ec7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24df66f1d97e12b0a82ab52dbc61f075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08ebdd3f053439ddc8280b9b8f3aed30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a69bebe0050e347949b15459414077ef |
| publicationDate |
2010-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2217704-A1 |
| titleOfInvention |
Method for the promotion of angiogenesis, vascularization, or vascular repair or for the inhibition of tumor angiogenesis |
| abstract |
The invention relates to a method for influencing miR-92 expression in a cell, comprising the following steps: (a) a cell is provided; and (b1) miR-92 expression in the cell is reduced in order to promote vascularization or vascular repair by introducing an antisense molecule against miR-92 into the cell, or (b2) miR-92 expression in the cell is increased in order to inhibit tumor angiogenesis by introducing a construct into the cell, said construct containing an expressible miR-92 sequence. The invention further relates to a pharmaceutical composition containing an agent for reducing miR-92 activity or expression in a cell in the form of an antisense molecule against miR-92, or an agent for increasing miR-92 expression in a cell in the form of a construct for expressing miR-92. |
| priorityDate |
2007-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |